Dr. Daniel Bouland Appointed Chief of the Division of Hospital Medicine

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Wolfgang Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

The Department of Medicine is very pleased to announce the appointment of Dr. Daniel Bouland as chief of the Division of Hospital Medicine effective July 1, 2016. Dr. Bouland will work with the Chair of Medicine and the CEO of the Health System to ensure continued growth of the division; additionally, Dr. Bouland will also continue to support the department of medicine in a new role as Vice Chair for Clinical Quality Improvement and Patient Experience.

Dr. Daniel L. Bouland

Daniel L. Bouland, MD, MS, FACP

Dr. Bouland is highly regarded as a clinician and educator as well as being an experienced leader in health care management and administration with vast experience in the field of hospital medicine across various governmental and private sectors.

Dr. Bouland received his medical training at Loma Linda University School of Medicine and completed an internal medicine residency at the same institution, serving an additional year as chief medical resident at affiliated Riverside General Hospital/University Medical Center (RGH/UMC). Commitments with the United States Public Health Service afforded Dan opportunities to work with indigent populations in southern California as well as the Indian Health Service. Upon his subsequent return to RGH/UMC, Dr. Bouland was progressively appointed Assistant, Associate, and then Chair of the Department of Medicine. During this time, additional functions included vice-chair of the Department of Medicine and Associate Program Director, Internal Medicine Residency Program, Loma Linda University Medical Center; president of hospital-based physicians RGH/UMC; and CEO/President of the Mission Medical Group of the Inland Empire. Of note internationally, in addition to lectures and clinical care, is his establishing and maintaining a US-style medicine residency program at Sir Run Run Shaw Hospital, Zhejiang Medical University in Hangzhou, China.

In 2000, Dan moved to Hawaii to serve as Associate Chief of Staff for Primary Care and Medicine of the Veterans Affairs Pacific Islands Health Care System (VAPIHCS), and then as Director of the Office of Referral and Management Services of the VAPIHC.

After joining the UCSD Division of Hospital Medicine in 2006, Dan completed a Master’s program in Health Care Management at Harvard. He has taken on many leadership roles within the University, including serving as Vice Chair for Clinical Operations in the department of medicine and as Director of Evaluation for the Altman Clinical and Translational Research Institute.

Current research efforts focus primarily on Quality Improvement initiatives, particularly the application of a results-oriented, business management approach to health care.

Please join me in congratulating Dr. Bouland in his formal appointment as Chief of the Division of Hospital Medicine.

In Memoriam: Nathan J. Zvaifler, MD

An announcement from Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Dr. Nathan J. Zvaifler

Dr. Nathan J. Zvaifler

Emeritus professor Nathan J. Zvaifler, MD, former chief of the Division of Rheumatology, Allergy & Immunology and a founder and influential leader in the Department of Medicine, passed away on January 28 at the age of 87.

Dr. Zvaifler was internationally known for his research and academic leadership. Here at UC San Diego, he was also beloved for his generosity in teaching and mentorship. Although he retired to emeritus status officially in 2008, he remained active in his instructional activities for years later.

Dr. Zvaifler left his stamp not only on the successful growth of the academic division he led for two decades but also on the character of the Department of Medicine and the School of Medicine.

In 1970, he was recruited from Georgetown University, where he had led the Arthritis Unit since 1961, to head the rheumatology division in the new medical school at UC San Diego.

From 1972 to 1974, he served as acting chair of the Department of Medicine after founding chair Eugene Braunwald left to take a position at the Peter Bent Brigham Hospital of the Harvard Medical School.

This was a period that subsequent Department of Medicine Chair Dr. Helen M. Ranney later described as “a crucial two years in the development of the new School of Medicine at UCSD.”

Dr. Zvaifler spent his entire career at UC San Diego.

A lectureship, the Rheumatology Lectureship Fund, was established in Dr. Zvaifler’s name by the Division of Rheumatology, Allergy and Immunology in 2008. Its purpose is to bring internationally recognized investigators to UC San Diego for seminars and teaching activities. More detail can be found at http://raidivision.ucsd.edu/About/giving/Pages/give-zvaifler.aspx.

Contributions in Dr. Zvaifler’s memory can be made to the Rheumatology Research Foundation of the American College of Rheumatology.

The American College of Rheumatology conducted a 75th Anniversary Interview with Dr. Zvaifler in 2009.

In Memoriam: Martin F. Kagnoff, MD

Announcement from Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Dr. Martin Kagnoff

Martin F. Kagnoff, MD

It is with sadness that I announce that we have lost one of our department’s most vigorous and inspiring leaders. Martin Kagnoff, MD, passed away at his home in La Jolla on Sunday, November 16.

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Dr. Kagnoff was Professor of Medicine and Pediatrics, Emeritus, and Director of the Laboratory of Mucosal Immunology at UC San Diego. He was a pioneer in academic gastroenterology and research.

He joined the faculty of the Division of Gastroenterology when he completed his residency and fellowship training in 1972. He devoted all 42 years of his long and fruitful career to UC San Diego.

Dr. Kagnoff directed the multidisciplinary Laboratory of Mucosal Immunology, which was established in 1985. His research initially focused on basic immunology in the gastrointestinal tract. He went on to the pathophysiology of celiac disease, the intestinal manifestations of AIDS, the biology of intestinal epithelial cells and the pathogenesis of enteric infections.

He was recognized worldwide as a leader in mucosal immunology and the mechanisms leading to celiac disease. He was dedicated to education at all levels and he trained nearly 100 students, post-doctoral fellows and junior faculty members.

Dr. Kagnoff’s research was continuously funded by the National Institutes of Health for 40 years. He published more than 200 papers in leading gastroenterology, immunology and basic science journals and edited multiple books and reviews.

He served as associate editor and editor-in-chief of two leading journals in the field: The Journal of Clinical Investigation and the American Journal of Physiology: Gastrointestinal and Liver Physiology.

Dr. Kagnoff earned his MD degree at Harvard Medical School. He received his postgraduate training in gastroenterology and immunology at Brigham and Women’s Hospital, Harvard Medical School, Boston University School of Medicine and the Salk Institute for Biological Studies.

His family conducted a memorial service on November 18.

Gifts in memory of Dr. Martin Kagnoff may be made payable to The Regents of the University of California referencing the Kagnoff Endowed Fund #16203 and mailed to UC San Diego, 9500 Gilman Drive #0940, La Jolla, CA 92093-0940.

Sanford Shattil, MD, Stepping Down as Hematology-Oncology Chief; Remains Fellowship Program Director

Announced August 21, 2014, by Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Sanford Shattil, MD

Sanford Shattil, MD

Please join the Department of Medicine in extending a sincere thank you to Sanford (Sandy) Shattil, MD, who will be stepping down as chief of the Division of Hematology-Oncology after ten years of service. He will be succeeded by Dr. Razelle Kurzrock.

Dr. Shattil will remain the director of the Hematology-Oncology Fellowship Training Program.

Dr. Shattil earned his Bachelor of Arts in psychology at the University of Illinois in Champaign-Urbana in 1964 and went on to receive his medical degree from the University of Illinois, College of Medicine in Chicago in 1968.

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

He completed his residency in internal medicine on the Harvard Medical Service of the Boston City Hospital and a fellowship in hematology at Boston City Hospital’s storied Thorndike Memorial Laboratory.

After a stint in the U.S. Public Health Service in San Francisco, he moved to the University of Pennsylvania in 1973, where he rose through the ranks to become professor of medicine and chief of hematology-oncology.

Razelle Kurzrock, MD

Razelle Kurzrock, MD

In 1995 he moved to The Scripps Research Institute in La Jolla, and in 2004 he was recruited to become division chief and professor of medicine at UCSD.

During Dr. Shattil’s tenure as the chief of hematology-oncology at UCSD, he has overseen major growth in the patient care, research and educational missions of the division. His vision has been to foster the careers of faculty and fellows in the context of all aspects of the division’s multiple missions and to work with other leaders at the Moores Cancer Center in expanding clinical services in a patient-centric manner.

Dr. Shattil will remain the department’s director of the Hematology-Oncology Fellowship Training Program, a role in which he has served since 2008. He will also continue his long-standing NIH-supported research program into basic and translational aspects of integrin adhesion receptor function for which he is recognized internationally, and he will maintain his clinical hematology practice, both in the inpatient setting and at Moores.

Please join me in expressing our sincere appreciation to Dr. Sandy Shattil for bringing his talents and expertise to both the Division of Hematology-Oncology and the Department of Medicine. We look forward to his continued service.

New Division Chief and Vice Chief of Endocrinology and Metabolism

Announced July 28, 2014, by Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Dr. Nicholas Webster

Nicholas Webster, PhD

I am pleased to announce that an internal review committee has selected Dr. Nick Webster as the new chief of the Division of Endocrinology and Metabolism in the Department of Medicine. Dr. Nai-Wen Chi has been selected to serve as vice chief.

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

I would like to express my gratitude to Dr. Nick Webster, who accepted the role of interim division chief after I stepped down in 2010. In leading the Division of Endocrinology and Metabolism for the past four years, Dr. Webster has done an important service for the division and the department.

Nick Webster, PhD, professor of medicine, is Associate Director for Shared Resources at the Moores Cancer Center and holds a joint appointment as a Senior Research Career Scientist at the VA San Diego Healthcare System. He is a highly respected researcher and thought leader in the field of endocrinology and metabolism.

Dr. Webster earned his B.A. and M.A. from Cambridge University and his Ph.D. from Stanford University.  After a post-doctoral fellowship at the CNRS in Strasbourg, France, he joined the UCSD faculty in the Division of Endocrinology and Metabolism in 1989 and was promoted to Professor in 2006.

Dr. Webster has been very active in service to the University and the Veterans Affairs San Diego Healthcare System (VASDHS).  He has held a number of leadership positions at UCSD, including Associate Vice Chancellor for Research Facilities in the Office of Research Affairs, where his portfolio included oversight of the animal welfare program and university-wide shared resources.  Dr. Webster has served as chair of a number of university committees, including the Radiation Safety and Surveillance Committee, the Animal Program Oversight Committee, the Recruitment and Admission Committee for the Biomedical Sciences Graduate Program, the Shared Resources Oversight Committee, and the Research Space Committees at the VASDHS.

Over the past 25 years, Dr. Webster has maintained an active research program, which is broadly focused on the mechanisms of hormonal signal transduction and gene regulation in different developmental and disease contexts.  He actively participates in the Center for Reproductive Science and Medicine, the Diabetes Research Center, and the Center for Transdisciplinary Research in Energetics and Cancer.

Nai-Wen Chi, MD, PhD

Nai-Wen Chi, MD, PhD

The newly appointed vice chair of the Division of Endocrinology and Metabolism, Dr. Nai-Wen Chi, is a researcher and board-certified endocrinologist at the UCSD Medical Center and the VA. Dr. Chi earned his M.D. from National Taiwan University prior to receiving his Ph.D. from Harvard University, where he was mentored by Dr. Richard Kolodner in investigating the molecular machinery that maintains the yeast mitochondrial genome.  Dr. Chi then completed his medical residency and endocrine fellowship at the Massachusetts General Hospital.  During his postdoctoral fellowship at MIT, he was mentored by Dr. Harvey Lodish in identifying novel insulin-signaling molecules that regulate vesicular trafficking.

Dr. Chi joined the UCSD faculty in 2000 and has been the director of the Endocrine Fellowship since 2005.  His clinical interest focuses on dysnatremias while his research program takes biochemical and genetic approaches to investigate the pathophysiology of diabetes and obesity.

Please join me in giving your enthusiastic support to Drs. Nick Webster and Nai-Wen Chi in their new positions of leadership in the Department of Medicine.

Dr. Catriona Jamieson Announced as Inaugural Chief of New Division of Regenerative Medicine

Announced today by Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

Catriona H. M. Jamieson, MD, PhD

Catriona Jamieson, MD, PhD

Please join me in officially welcoming Catriona Jamieson, MD, PhD, as the inaugural chief of the new Division of Regenerative Medicine. The Department of Medicine is delighted to announce the inception of the Division of Regenerative Medicine and we enthusiastically support Dr. Jamieson’s talent and vision for this innovative endeavor.

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Dr. Jamieson joined the UC San Diego faculty in 2005 and is an associate professor of Medicine in the Division of Hematology-Oncology. She has proven her leadership skills, expertise and effectiveness in her current positions as director of the Stem Cell Research Program at Moores Cancer Center, co-leader of the Hematologic Malignancies Program, hematology team leader, co-director of the UC San Diego Stem Cell Training Grant, coordinating course director of the Interdisciplinary Stem Cell course, and a co-director of the new Sanford Stem Cell Clinical Center.

Dr. Jamieson received her medical and doctorate degrees from the University of British Columbia. She completed her residency and clinical fellowships in bone marrow transplantation and hematology, as well as her postdoctoral research fellowship in the laboratory of Professor Irving Weissman at Stanford.

As a physician-scientist, Dr. Jamieson specializes in leukemia and myeloproliferative neoplasms, which are a family of uncommon, but not rare, degenerative disorders in which the body overproduces blood cells. These disorders can cause blood clotting which can lead to heart attack, stroke, and other life-threatening complications including transformation to acute leukemia. Dr. Jamieson’s research focuses on the mutant stem cells and progenitor cells in myeloproliferative neoplasms, which can give rise to cancer stem cells. Her stem-cell research studies have taken a substantial leap from identifying a promising treatment in the laboratory to completing the first clinical trial targeting cancer stem cells in humans. Her discoveries in myeloproliferative neoplasms are now being brought together with a drug development track of a regional pharmaceutical company.

Please join me in giving your enthusiastic support to Dr. Jamieson in her new leadership role as the inaugural chief of the Division of Regenerative Medicine here at UC San Diego. This is a unique and exciting opportunity to make UC San Diego a key hub for the rapid translation of stem cell discoveries to the clinic.

Joachim H. Ix Named Chief of Nephrology-Hypertension

January 2, 2014

Announcement from Wolfgang H. Dillmann, MD
Helen M. Ranney Distinguished Professor and Chair

Dr. Joachim Ix

Dr. Joachim Ix

I am very pleased to announce that Dr. Joachim H. Ix, who has served as interim chief of the Division of Nephrology-Hypertension since Dr. Roland Blantz retired in 2012, has been selected as the new chief of the division. His new appointment was effective December 17, 2013.

Dr. Ix has managed the division with effectiveness and wisdom during his year as interim chief, balancing and advancing its activities during a time that has brought particularly difficult fiscal and managerial challenges to all of us. I am confident that the Division of Nephrology-Hypertension will continue to grow in clinical and academic stature with his leadership.

Joachim H. Ix, MD, MAS, is professor of medicine and professor of family and preventive medicine at UC San Diego. He is active as a clinical specialist in the diagnosis and management of kidney disease patients at both UC San Diego Health System and the Veterans Affairs San Diego Healthcare System (VASDHS). He directed the VASDHS chronic kidney disease clinic in 2008-2009 and subsequently the VASDHS Dialysis Unit from 2009-2013.

A creative and productive clinical trialist and epidemiologist, Dr. Ix investigates the contributions of altered calcium and phosphorus homeostasis to cardiovascular disease in patients with kidney disease. He has more than 140 published articles in peer-reviewed journals. His active National Institutes of Health funded studies include a 5-year U01 cooperative project, begun in September of this year, in which he will conduct a phase 2 clinical trial to test the efficacy of nicotinamide (vitamin B3) on phosphorus homeostasis and other components of mineral metabolism in CKD patients. He is also PI of a recently funded R01 award evaluating the contributions of kidney tubule dysfunction and injury to progression of kidney disease and cardiovascular disease, and was recently funded as PI of an American Heart Association Established Investigator Award.

He was elected a fellow of the American Society of Nephrology in 2010 and is associate editor of the American Journal of Kidney Diseases, a standing member of the NIH Study Section on Kidney Nutrition Obesity and Diabetes (KNOD) and a member of the SPRINT Trial Chronic Kidney Disease Advisory Group.

Dr. Ix is a dedicated teacher and mentor and an active contributor to his division’s instructional efforts at all levels, including the nephrology fellowship program and the School of Medicine curriculum. In 2010, he received the Excellence in Teaching Award in recognition for outstanding teaching contributions in the third-year Medicine Core Clerkship course.

Dr. Ix earned his Bachelor of Science degree at UC San Diego and his medical degree at the University of Chicago Pritzker School of Medicine. He received his specialty training, nephrology fellowship training, and MAS in biostatistics and epidemiology at UC San Francisco. He joined the UC San Diego faculty in 2007.

Bruce Zuraw, MD, Is New Chief of Rheumatology, Allergy & Immunology Division

Announcement

From Wolfgang H. Dillmann, MD
Helen M. Ranney Distinguished Professor
Chair of the Department of Medicine

I am pleased to announce that an internal review committee has selected Dr. Bruce Zuraw as the new chief of the Division of Rheumatology, Allergy & Immunology in the Department of Medicine. He is also inaugural holder of the US Hereditary Angioedema Association (HAEA) Endowed Chair.

I would like to express my gratitude to Dr. Robert Terkeltaub, who accepted the role of interim division chief after Dr. Gary Firestein stepped down in June 2010. In leading the Division of Rheumatology, Allergy & Immunology for the past three years, Dr. Terkeltaub has done an important service for the division and the department.

Bruce L. Zuraw, MD, professor of medicine, is Director of the Section of Allergy and Immunology at the Veterans Affairs San Diego Healthcare System and head of the Allergy & Immunology section of the Division of Rheumatology, Allergy & Immunology at UC San Diego. He directs the Allergy and Immunology Fellowship Program.

Dr. Zuraw is a highly respected clinician, researcher and thought leader in the field of allergy and immunology and an internationally recognized expert in hereditary angioedema. He chairs the Medical Advisory Board of the US Hereditary Angioedema Association (HAEA) and will direct the newly established US HAEA Angioedema Center at UC San Diego.

Dr. Zuraw joined the faculty of the UC San Diego School of Medicine in 2004 after many years as a fellow, clinician, researcher and leader at Scripps Clinic & Research Foundation and The Scripps Research Institute.

He was born in Brookline, Massachusetts, and received his undergraduate degree in biology from Carleton College in Northfield, Minnesota, in 1972. He earned his M.D. degree and completed his internal medicine residency training at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois.

Dr. Zuraw received his fellowship training and established his research and clinical career in allergy and immunology at Scripps Clinic and Research Foundation and The Scripps Research Institute in La Jolla. There, he rose to the rank of associate professor in the Department of Molecular and Experimental Medicine and held a number of leadership positions, including director of the Allergy & Immunology Fellowship Training Program, associate director of the General Clinical Research Center and director of research for the Scripps Internal Medicine Residency Program.

Dr. Zuraw has been very active in service to the University and the Veterans Affairs San Diego Healthcare System. In addition to his divisional and educational program leadership positions, he has chaired the VA Research Space Committee and served on the DOMCAP Committee. He is currently on the VA Research Information Security Subcommittee and the Intern Selection Committee of the UCSD Internal Medicine Residency Program.

In his research, Dr. Zuraw is a highly respected investigator in the area of allergic inflammation in humans, with particular attention to hereditary angioedema, and the mechanism of action of glucocorticoids. He is principal investigator of a number of basic and clinical research projects including major projects funded by the National Institutes of Health, the Department of Defense, and the VA Merit program. He has published more than 120 peer-reviewed articles and nearly 50 invited reviews and book chapters.

Please join me in giving your enthusiastic support to Dr. Bruce Zuraw in his new position of leadership in the Department of Medicine.

Dr. Gregg Middleton: Q&A

Dr. Gregory MiddletonDr. Gregg Middleton is featured in the Getting to Know column in Making the Rounds, the UC San Diego Health System employee newsletter for April 24-30, 2013.  |  Read the story

Gregg Middleton, MD, is Health Sciences associate clinical professor in the Department of Medicine, Division of Rheumatology, Allergy & Immunology; and in the Department of Surgery. He specializes in osteoarthritis and the non-surgical care of patients with chronic joint and muscle pain.

In his research, Middleton investigates osteoarthritis, quality of life with chronic pain and medical management of chronic disease.

More Information:

In Memoriam: Virgil L. Woods, Jr., MD

Virgil L. Woods, Jr., MD
1948 – 2012

Dr. Virgil L. Woods, Jr.Virgil L. Woods, Jr., MD, pioneer in the field of proteomics and beloved teacher and clinician who spent his academic career at UC San Diego, died September 30 after an illness. He was 64 years old.

“We are very saddened at the loss of our colleague and friend,” said Wolfgang Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine.

Dr. Woods was professor of medicine in Rheumatology, Allergy & Immunology.

“He was an enthusiastic clinician and teacher, and brought a high level of energy and critical thinking skills to the teaching and clinical programs in rheumatology at UCSD,” said Robert A. Terkeltaub, MD (below), professor of medicine and interim chief of the division.

Robert Terkeltaub, MD“He was very generous in his service roles. He will be greatly missed in our program, on both a personal and professional level. He was truly one of a kind.”

“Virgil Woods was a gifted scientist, an outstanding clinician, a generous colleague, and an enthusiastic teacher,” said Mark H. Ginsberg, MD (below), colleague of Dr. Woods and a fellow rheumatologist.

Dr. Ginsberg is professor of medicine in the divisions of Rheumatology, Allergy & Immunology and Hematology-Oncology and director of the UCSD Physician-Scientist Training Program.

“Virgil was an active and engaged rheumatologist,” he said.

Dr. Mark Ginsberg“He taught his subspecialty and particularly relished working on the front lines of inpatient medicine as an academic hospitalist. In this role he assumed responsibility for acutely ill patients with a wide spectrum of conditions and was a major resource for young physicians.

“Virgil was always willing to share the clinical work load with his colleagues and was unfailingly generous in making time to teach fellows, residents, and students,” Ginsberg said.

In addition to his teaching activities within the Department of Medicine, Dr. Woods was a faculty member in the UCSD Biomedical Sciences and Bioinformatics and Systems Biology graduate programs.

“He was a fountain of clinical and research wisdom,” Dr. Ginsberg said, “and his untimely death is a loss to the UCSD community.”

Dr. Woods was a highly respected and productive physician-scientist. “Virgil was one of the first to use monoclonal antibodies to examine the functional role of platelet cell surface receptors,” Dr. Ginsberg said.

“In doing so, he raised some of the earliest antibodies that blocked the function of platelet integrins, antibodies that were prototypes for agents in current use in the clinic in a spectrum of diseases including multiple sclerosis and arterial thrombosis.”

In recent years, his research centered upon structural biology applications of an advanced proteomics technology.

“Virgil had a dream to use mapping of amino acids that were protected from chemical modification as a means to assess protein folding and identify sites involved in protein-protein interactions,” said Dr. Ginsberg. “With the advent of modern high-resolution protein mass spectroscopy, it was possible to analyze deuterium exchange of whole proteins as a means to study their higher order structure,” he said.

“Virgil’s singular contribution was to develop methods to proteolytically cleave proteins into peptides under conditions that prevented further deuterium exchange. This enabled him to map the accessibility of individual peptides in a folded protein, a technique called peptide amide hydrogen-deuterium exchange mass spectrometry (DXMS).”

In the following years, Dr. Woods and his colleagues refined the DXMS method, increasing its resolution and applying it in an expanding range of protein studies.

“His techniques have found wide applicability in the study of protein structures in the Structural Genomics Initiative and have been used around the world to assess protein-protein interactions,” Dr. Ginsberg said.

The work resulted in seven patents and earned considerable funding from the National Institutes of Health and other sources. Dr. Woods was the UCSD Technology Transfer Office’s Fall 2012 “Featured Pioneer.”

Dr. Woods directed the DXMS Proteomics Resource at UCSD and was actively collaborating with researchers at UCSD, The Scripps Research Institute, the Sanford-Burnham Medical Research Institute, the Salk Institute and other institutions in the United States and abroad.

“Virgil’s scientific achievements spring directly from his vision, dedication, and perseverance,” said Dr. Ginsberg. “He had a true scientific ‘green thumb.’ He could make things work when many others had tried and failed.”

Dr. Woods received his undergraduate training at UC San Francisco (BS, medical sciences) and UCSD (BA, biochemistry) and his MD degree at UC San Francisco. After interning and completing his residency at Barnes Hospital in St. Louis, Missouri, he came to UCSD as a rheumatology fellow in 1979.

He joined the Department of Medicine faculty when he completed his fellowship in 1981, and served UCSD for 31 years.

“Virgil was an outstanding colleague and faculty member by being an exceptional clinician, enthusiastic teacher and highly creative scientist,” said Dr. Dillmann.

Dr. Woods is survived by his wife, Betsy, and three children; his parents; and three brothers.
Profile of Dr. Woods

UCSD Press Releases About His Work